{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-24-000062","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2024-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.511078+00:00","generated_at":"2026-06-03T04:54:35.821988+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Stryker Q1 sales $5.2B (+9.7%), organic +10.0%; lifts FY organic growth view to 8.5-9.5%, adj. EPS $11.85-$12.05","bullets":["Reported EPS $2.05 (+33.1%); adjusted EPS $2.50 (+16.8%).","MedSurg & Neurotechnology organic sales +11.6%; Orthopaedics & Spine organic +8.0%.","Reported operating margin 18.5%; adjusted operating margin 21.9% (+80 bps).","FY 2024 organic net sales growth now expected 8.5% to 9.5% (prior range not disclosed).","Adjusted EPS guidance raised to $11.85-$12.05; expects negative FX impact of $0.05-$0.10."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-24-000062","json":"https://secwatch.observer/filing/0000310764-24-000062.json","markdown":"https://secwatch.observer/filing/0000310764-24-000062.md","text":"https://secwatch.observer/filing/0000310764-24-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000062/0000310764-24-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000062/syk-20240430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T04:54:35.821988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"74d9bc11923da4436d9b44e6d230fe30b65ebc8e","claim":"STRYKER CORP updated its first quarter 2024 guidance (raised).","evidence_excerpt":"Stryker Corporation issued a press release on April 30, 2024 announcing its first quarter 2024 operating results.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000062/0000310764-24-000062-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2024"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}